Alpha Teknova Shares Fall 22.3% After Announcing Public Offering of Common Stock
Key Facts
Alpha Teknova shares fell 22.3% in after-hours trading on Tuesday, October 20, 2026, after it announced a public offering of common stock, according to Investing.com. The company filed a preliminary prospectus supplement marked "subject to completion," alongside unaudited estimates of its third-quarter performance. In the prospectus, it projected revenue for the period of between $12.5 million and $12.7 million, providing a financial update as it seeks to raise equity financing. That range represents year-on-year growth of between 19% and 21%, according to the company's estimates in the offering prospectus. Potential uses of the funds raised include repaying existing debt obligations, according to details of the offering launch published by Investing.com.
On profitability, Alpha Teknova estimated a third-quarter gross margin range starting at 36.0%, according to the preliminary offering prospectus published on its website. The upper end of the margin estimate is 38.0%, leaving the entire range below the margin the company recorded in the second quarter of the same year. In its previous financial results, the company reported a second-quarter gross margin of 40.1%, the level preceding its new estimates for the following period. The second-quarter margin had improved from 38.7% in the corresponding period a year earlier, according to the company's earnings release. According to Investing.com, Alpha Teknova estimates its third-quarter adjusted loss before interest, taxes, depreciation and amortization at between $1 million and $1.2 million.
On liquidity, the company estimated cash and short-term investments at approximately $16.6 million at the end of the third quarter, according to preliminary information included in the offering prospectus. That balance is below the $17.4 million in cash and short-term investments the company reported at the end of the second quarter. Total borrowings stood at $13.2 million at the close of the second quarter, according to the earnings release published on Alpha Teknova's website. During the second quarter, free cash outflow declined to $0.6 million, according to the same release, which provided a comparison with the corresponding period a year earlier. Free cash outflow had totaled $2.3 million in that year-earlier period before declining in the reported quarterly results.
Alpha Teknova provides customizable solutions for customers in genomics, molecular diagnostics and emerging therapies, according to the description of its business in the second-quarter earnings release. The company's revenue for that quarter was $12.2 million, according to the results preceding the preliminary estimates now announced for the third quarter. The company compared its second-quarter revenue with $10.3 million in the corresponding quarter a year earlier, according to its published financial release. Revenue thus grew 18% year on year in the second quarter, ahead of the higher growth range the company projects in its estimates for the following period. Those previous results place the third-quarter estimates in the context of continued revenue growth, both compared with the previous quarter and year on year.
Alpha Teknova had raised its annual revenue outlook when it announced second-quarter results, according to the release, which also included an update to its free cash outflow forecast. The company set the lower end of its fiscal 2026 revenue forecast at $45 million within the revised annual range announced at the time. The same update put the upper end of annual revenue at $47 million, alongside the announcement of quarterly sales growth and an improved gross margin. On cash flow, the company lowered its forecast for free cash outflow during the same fiscal year, according to the second-quarter earnings release. It said it expected that outflow to be "less than $8 million," the annual estimate announced with those results.
In details of the offering announced on October 20, TD Cowen and William Blair are acting as joint book-running managers, according to the company's preliminary offering prospectus. Alpha Teknova intends to grant the underwriters an option to purchase additional shares, according to details of the offering launch reported by Investing.com. The option allows the purchase of shares amounting to up to 15% of the shares offered, with 30 days to exercise it. Completion of the offering remains subject to market conditions and other terms, according to the caution included in the company's launch announcement. Alpha Teknova warned that "there can be no assurance as to whether or when the offering will be completed," leaving the next step dependent on meeting the conditions for completion.